Beigneux, Anne P.

The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver

Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2000) · Journal of Biological Chemistry

Peroxisome Proliferator-Activated ReceptorsCholesterol and Lipid Metabolism

Cited by 223

Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf

Bergo, M. O., Gavino, B. J., Hong, C., Beigneux, A. P., McMahon, M., Casey, P. J., & Young, S. G. (2004) · Journal of Clinical Investigation

Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

Cited by 180

Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.

Olivecrona, G., Ehrenborg, E., Semb, H., Makoveichuk, E., Lindberg, A., Hayden, M. R., Gin, P., Davies, B. S. J., Weinstein, M. M., Fong, L. G., et al. (2010) · Journal of Lipid Research

Lipid metabolism and disordersLymphatic Disorders and Treatments

Cited by 118

The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.

Gin, P., Yin, L., Davies, B. S. J., Weinstein, M. M., Ryan, R. O., Bensadoun, A., Fong, L. G., Young, S. G., & Beigneux, A. P. (2008) · Journal of Biological Chemistry

Lipid metabolism and disordersLipid metabolism and biosynthesis

Cited by 85

Chylomicronemia elicits atherosclerosis in mice—brief report.

Weinstein, M. M., Yin, L., Tu, Y., Wang, X., Wu, X., Castellani, L. W., Walzem, R. L., Lusis, A. J., Fong, L. G., Beigneux, A. P., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipid metabolism and disordersCholesterol and Lipid Metabolism

Cited by 71

Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver

Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2003) · American Journal of Physiology-Endocrinology and Metabolism

Thyroid Disorders and TreatmentsEstrogen and related hormone effects

Cited by 64

Lipoprotein size and susceptibility to atherosclerosis—insights from genetically modified mouse models.

Young, S., Veniant, M., Beigneux, A., Bensadoun, A., & Fong, L. (2008) · Current Drug Targets

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 33